Searched for
TREATMENT OF SCHIZOPHRENIA
Could owning a cat bring health risks? Study suggests it may double the chances of a ‘serious mental health condition’New research suggests owning a cat could double the risk of schizophrenia-related disorders. A meta-analysis of 17 studies found a link bet...- Lupin launches generic injection in US with 180-day exclusivityIn an exciting development for mental health treatment, Lupin has introduced a generic version of a medication for schizophrenia and bipola...
- Lupin gets USFDA nod for generic risperidone extended-release injectable suspensionLupin Ltd. secured USFDA approval for its generic risperidone extended-release injectable suspension, a treatment for schizophrenia and bip...
- Zydus gets US nod for schizophrenia generic medicineZydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release tablets, which are...
- Alembic Pharma gets USFDA nod for generic drug used to treat schizophreniaAlembic Pharmaceuticals has received final approval from the USFDA for its generic version of Paliperidone extended-release tablets, used t...
- Alembic Pharma gets USFDA nod to market generic antidepressant drugThe company's product is therapeutically equivalent to Otsuka Pharmaceutical Co's reference listed drug product Rexulti tablets, it added. ...
- It's not easy to notice symptoms of schizophrenia in an early stage. Hallucination, delusion and other signs to watch out forSchizophrenia generally manifests itself during puberty.
- Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drugIn a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP i...
- Cadila Healthcare gets USFDA nod for Haloperidol Decanoate injectionHaloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome.
- Zydus gets USFDA nod for schizophrenia treatment drugThe company has got final approval from the USFDA to market the drug in the strengths of 25 mg, 50 mg, 100 mg and 200 mg, Zydus Cadila said...
- Shock therapy returns to cure mental illnessFirst developed in 1938, electroconvulsive therapy, for years, had a poor reputation with many negative depictions in movies, books, and me...
- Zydus Pharma Inc recalls 9,504 bottles of Risperidone tabletsRisperidone tablets are used in the treatment of schizophrenia. "The reason for recall is "out of specification for a known degradant," it ...
- Smartphone game may improve memory in schizophrenicsResearchers have developed a smartphone 'brain training' game that may improve the memory & daily functioning of patients with schizophreni...
- Schizophrenia not a single disease: StudySchizophrenia is not a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms, scientists ha...
- Suven gets four new drug molecule patents in four countriesSuven Life Sciences Ltd gets four product patents one each from Australia, Canada, Korea and New Zealand for their new drug molecules (New ...
- Zydus Cadila gets USFDA nod for schizophrenia drugThe company got a tentative approval for aripiprazole orally disintegrating tabs in the strengths of 10 mg, 15 mg, 20 mg and 30 mg.
- Aurobindo receives Australia nod for schizophrenia, osteoporosis drugsAurobindo Pharma has received approval from the Australian health authority to market Risperidone and Alendronate tablets.
- Suven gets patent grants for 2 products in Mexico, KoreaSuven Life Sciences has received patent grants for their two products in Mexico and Korea.
- Suven receives two product patents associated with NeurodegenerativeSuven Life Sciences has received two product patents in Eurasia for two new chemical entities for the treatment of disorders associated wit...
- Ranbaxy got USFDA nod for RisperdalThe country's largest drugmaker Ranbaxy Laboratories received the US food and drug administration (USFDA) nod to sell generic version of Ri...
Load More
